Patents Assigned to Sun Pharmaceutical Industries Ltd.
-
Patent number: 9717800Abstract: The present invention relates to a pharmaceutical composition comprising fingolimod and a weak acid cation exchange resin in the form of an ion-exchange complex and pharmaceutically acceptable 5 excipients.Type: GrantFiled: September 1, 2015Date of Patent: August 1, 2017Assignee: SUN PHARMACEUTICAL INDUSTRIES LTD.Inventors: Sunil Jaiswal, Krishna Sharma, Nitin Bhalachandra Dharmadhikari, Shirish Kulkarni
-
Patent number: 9707182Abstract: The present invention relates to novel oral sustained release pharmaceutical dosage forms for delivery of budesonide to the lower gastrointestinal tract for the treatment of Crohn's disease.Type: GrantFiled: September 9, 2016Date of Patent: July 18, 2017Assignee: Sun Pharmaceutical Industries LTD.Inventors: Rajamannar Thennati, Shirish Kulkarni, Amol Kulkarni, Vimal Kaneria, Mukesh Sharma
-
Publication number: 20170071863Abstract: The present invention relates to novel oral sustained release pharmaceutical dosage forms for delivery of budesonide to the lower gastrointestinal tract for the treatment of Crohn's disease.Type: ApplicationFiled: September 9, 2016Publication date: March 16, 2017Applicant: Sun Pharmaceutical Industries Ltd.Inventors: Rajamannar Thennati, Shirish Kulkarni, Amol Kulkarni, Vimal Kaneria, Mukesh Sharma
-
Publication number: 20160367476Abstract: A method of treating a patient in need of therapy with fentanyl or a salt thereof, the method comprising providing a ready-to-administer solution consisting essentially of fentanyl or a salt thereof as the sole active ingredient, a sugar or sugar alcohol and water for injection, the solution having a pH in the range of 3.5 to 7.5, and parenterally administering the solution to the patient.Type: ApplicationFiled: June 17, 2016Publication date: December 22, 2016Applicant: SUN PHARMACEUTICAL INDUSTRIES LTD.Inventors: Samarth KUMAR, Prashant KANE, Subhas Balaram BHOWMICK, Milan Natvarbhai THAKKAR, Kandarp Maheshkumar DAVE
-
Publication number: 20160058715Abstract: The present invention relates to a ready-to-administer parenteral dosage form of norepinephrine which comprises an aqueous solution of norepinephrine, having an anti-oxidant which is not a sulfite anti-oxidant, wherein the dosage form is stable at room temperature for prolonged period of time.Type: ApplicationFiled: August 27, 2015Publication date: March 3, 2016Applicant: SUN PHARMACEUTICAL INDUSTRIES LTD.Inventors: Thummar RAKESH, Pawar SHANTARAM, Kane PRASHANT, Bhowmick Subhas BALARAM, Kumar SAMARTH, Thakkar Milan NATVARBHAI, Dave Kandarp MAHESHKUMAR
-
Patent number: 9241948Abstract: A large volume infusion dosage form of gemcitabine, comprising a stable large volume solution of gemcitabine or its pharmaceutically acceptable salt in an aqueous vehicle filled in a large volume infusion container, wherein the solution is ready-to-be-infused.Type: GrantFiled: April 26, 2013Date of Patent: January 26, 2016Assignee: Sun Pharmaceutical Industries Ltd.Inventors: Samarth Kumar, Prashant Kane, Alok B. Namdeo, Subhas B Bhowmick, Kirti Ganorkar
-
Publication number: 20150366981Abstract: The present invention relates to a pharmaceutical composition comprising fingolimod and a weak acid cation exchange resin in the form of an ion-exchange complex and pharmaceutically acceptable 5 excipients.Type: ApplicationFiled: September 1, 2015Publication date: December 24, 2015Applicant: SUN PHARMACEUTICAL INDUSTRIES LTD.Inventors: Sunil JAISWAL, Krishna SHARMA, Nitin Bhalachandra DHARMADHIKARI, Shirish KULKARNI
-
Publication number: 20150165057Abstract: The present invention relates to a pharmaceutical composition comprising fingolimod and a weak acid cation exchange resin in the form of an ion-exchange complex and pharmaceutically acceptable excipients.Type: ApplicationFiled: February 25, 2015Publication date: June 18, 2015Applicant: SUN PHARMACEUTICAL INDUSTRIES LTD.Inventors: Sunil JAISWAL, Krishna SHARMA, Nitin Bhalachandra DHARMADHIKARI, Shirish KULKARNI
-
Publication number: 20140031550Abstract: The present invention relates to an improved process for preparing morphinane analogues of formula 1 wherein the substituents R1, R2, R2a, R3, R4, R5 and Y have the meanings as defined in the specifications.Type: ApplicationFiled: August 29, 2013Publication date: January 30, 2014Applicant: Sun Pharmaceutical Industries Ltd.Inventors: Nileshkumar Sureshbhai PATEL, Srinivasu KILARU, Rajamannar THENNATI
-
Publication number: 20130288994Abstract: A large volume infusion dosage form of gemcitabine, comprising a stable large volume solution of gemcitabine or its pharmaceutically acceptable salt in an aqueous vehicle filled in a large volume infusion container, wherein the solution is ready-to-be-infused.Type: ApplicationFiled: April 26, 2013Publication date: October 31, 2013Applicant: SUN PHARMACEUTICAL INDUSTRIES LTD.Inventors: Samarth Kumar, Prashant Kane, Alok B. Namdeo, Subhas B. Bhowmick, Kirti Ganorkar
-
Patent number: 8471016Abstract: The present invention provides a process for preparing a compound of formula (I), or a pharmaceutically acceptable salt thereof, having the R-configuration, of formula (IA), or S-configuration of formula (IB), selectively over the other enantiomer.Type: GrantFiled: April 28, 2011Date of Patent: June 25, 2013Assignee: Sun Pharmaceutical Industries Ltd.Inventors: Kanaksinh Jesingbhai Jadav, Rutvij Manharlal Bhatt, Kamleshkumar Naranbhai Borkhataria, Trinadha Rao Chitturi, Rajamannar Thennati
-
Publication number: 20130102811Abstract: The present invention relates to a novel and improved process for the preparation of lacosamide, wherein the process is a sequential one-pot process.Type: ApplicationFiled: July 1, 2011Publication date: April 25, 2013Applicant: SUN PHARMACEUTICAL INDUSTRIES LTDInventors: Maheshbhai Mehulkumar Patel, Vishal Diliprao Mohite, Sudhakar Khambampati, Rao Trinadha Chitturi, Rajamannar Thennati
-
Patent number: 8426470Abstract: A method of alleviating signs and symptoms of spasticity in human patient comprising orally administering to said human patients once in a day a controlled drug delivery system comprising an effective daily dose of baclofen or its pharmaceutically acceptable salt. The controlled drug delivery system is operable to produce a level of sedation lower than a sedation produced by three times a day immediate release tablets. A total daily dosage of the controlled release tablets and a total daily dosage of the three times a day immediate release tablets remain same.Type: GrantFiled: April 25, 2007Date of Patent: April 23, 2013Assignee: Sun Pharmaceutical Industries Ltd.Inventors: Nitin Bhalachandra Dharmadhikari, Yashoraj Rupsinh Zala
-
Publication number: 20130041150Abstract: The present invention provides a process for preparing a compound of formula (I), or a pharmaceutically acceptable salt thereof, having the R-configuration, of formula (IA), or S-configuration of formula (IB), selectively over the other enantiomer.Type: ApplicationFiled: April 28, 2011Publication date: February 14, 2013Applicant: SUN PHARMACEUTICAL INDUSTRIES LTDInventors: Kanaksinh Jesingbhai Jadav, Rutvij Manharlal Bhatt, Kamleshkumar Naranbhai Borkhataria, Trinadha Rao Chitturi, Rajamannar Thennati
-
Publication number: 20110149490Abstract: Provided is a container of a display device. The container includes a lower protector on which the display device is seated and an upper protector covering the lower protector. The lower protector includes a display seat on which a lower portion of the display device is seated and openings for exposing a functional part of the display device provided in the lower portion of the display device to the outside of the lower protector in a state where the display device is seated on the display seat.Type: ApplicationFiled: December 24, 2008Publication date: June 23, 2011Applicant: SUN PHARMACEUTICAL INDUSTRIES LTDInventors: Young-Moo Seo, Hyo-Sang Park, Eui-Su Kim
-
Publication number: 20090264469Abstract: The present patent application concerns new compounds of formula (I): displaying agonistic activity at sphingosine-1-phosphate (S1P) receptors, their process of preparation and their use as immunosuppressive agents.Type: ApplicationFiled: October 18, 2005Publication date: October 22, 2009Applicants: BIO-PROJET, SUN PHARMACEUTICAL INDUSTRIES LTD.Inventors: Marc Capet, Nicolas Levoin, Isabelle Berrebi-Bertrand, Olivia Poupardin, Philippe Robert, Jean-Charles Schwartz, Jeanne-Marie Lecomte, Thennati Rajamannar, Ranjan Kumar Pal, Biswajit Samanta, Jignesh K. Jivani, Bhavesh M. Panchal, Isha H. Bhatt, Jayraj D. Aradhye
-
Patent number: 7550605Abstract: The present invention provides optically pure (S)-(+)-N-methyl-3-(1-naphthaleneoxy)-3-(2-thienyl)propanamine, a compound of formula (I), and optically pure (S)-isomer of compound of formula 4, wherein R1 and R2 both are methyl or R1 is methyl and R2 is benzyl or substituted benzyl group and process for preparation thereof. Formula (I) and (IV). In another aspect the present invention provides a process for preparation of an acid addition salt of compound of formula (I).Type: GrantFiled: August 5, 2005Date of Patent: June 23, 2009Assignee: Sun Pharmaceutical Industries Ltd.Inventors: Kartik Shantilal Patel, Nischal Vinodbhai Patel, Rajeev Budhdev Rehani, Rajamannar Thennati
-
Publication number: 20080177096Abstract: The present invention provides a process for preparation of 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofuran car-bonitrile comprising reacting a compound of formula IVa, in the presence of a base with a compound of formula RX, wherein R is selected from alkyl, alkenyl, aryl and heteroaryl which may be optionally substituted with electron withdrawing groups and X is selected from F, Cl, Br, I, CN, OTf and OR1, wherein Tf represents trifluoromethanesulfonyl group, and R1 is optionally substituted alkyl, Z is a cyano group or a group that may be converted to a cyano group; further wherein RX is selected such that an intermediate ether derivative, a compound of formula Va formed from said reaction cyclizes to a compound of formula VI, and where Z is not a cyano group, conversion of the group Z in the compound of formula VI to a cyano group to form 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofuran carbonitrile.Type: ApplicationFiled: February 1, 2008Publication date: July 24, 2008Applicant: Sun Pharmaceutical Industries Ltd.Inventors: Periyandi Nagarajan, Kilaru Srinivasu, Thennati Rajamannar
-
Publication number: 20080138403Abstract: A pharmaceutical dosage form comprising a mixture of a therapeutically effective amount of oxcarbazepine having median particle size ranging from about 15 ?m to about 26 ?m and one or more hydrophilic polymers, said mixture being formed by subjecting a suspension comprising said oxcarbazepine and a hydrophilic polymer in a solvent, to mixing in a homogenizer, optionally removing the solvent and converting the said mixture into a dosage form.Type: ApplicationFiled: October 25, 2007Publication date: June 12, 2008Applicant: Sun Pharmaceutical Industries Ltd.Inventors: Ashish Prabhakar Mungre, Nitin Bhalachandra Dharmadhikari
-
Publication number: 20060270858Abstract: The present invention provides a process for preparation of 1-[9H-carbazol-4-yloxy]-3-[{2-(2-(methoxy)phenoxy)-ethyl}-amino]-propan-2-ol, a compound of formula 1 in racemic form or in the form of optically active R or S enantiomer or its pharmaceutically acceptable salt, comprising, reacting 4-(oxiranylmethoxy)-9H-carbazole, a compound of formula (2) or the R or S enantiomer thereof with a compound of formula (5), wherein R1 is benzyl or substituted benzyl group, in an aprotic organic solvent in presence of a catalyst to obtain a compound of formula (6), or the R or S enantiomer thereof, wherein R1 is as defined above. The resultant compound of formula (6) is subjected to debenzylation reaction by catalytic hydrogenation to obtain the compound of formula (1), if desired converting the resultant compound of formula (1) to a pharmaceutically acceptable salt thereof.Type: ApplicationFiled: March 4, 2004Publication date: November 30, 2006Applicant: Sun Pharmaceutical Industries LtdInventors: Vijay Chhabada, Rajeev Rehani, Rajamannar Thennati